Identification of Necrosis-Associated Genes in Glioblastoma by cDNA Microarray Analysis

Clinical Cancer Research - Tập 10 Số 1 - Trang 212-221 - 2004
Shaan M. Raza1, Gregory N. Fuller2, Chang Hun Rhee3, Suyun Huang1, Kenneth R. Hess4, Wei Zhang2, Raymond Sawaya1
11Departments of Neurosurgery,2
2Pathology, and3
3Department of Neurosurgery, Korean Cancer Center Hospital, Seoul, Korea
4Biostatistics, Brain Tumor Center, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, and4

Tóm tắt

Abstract Purpose: In the field of cancer research, there has been a paucity of interest in necrosis, whereas studies focusing on apoptosis abound. In neuro-oncology, this is particularly surprising because of the importance of necrosis as a hallmark of glioblastoma (GBM), the most malignant and most common primary brain tumor, and the fact that the degree of necrosis has been shown to be inversely related to patient survival. It is therefore of considerable interest and importance to identify genes and gene products related to necrosis formation. Experimental Design: We used a nylon cDNA microarray to analyze mRNA expression of 588 universal cellular genes in 15 surgically resected human GBM samples with varying degrees of necrosis. Gene expression was correlated with the degree of necrosis using rank correlation coefficients. The expression of identified genes was compared with their expression in tissue samples from 5 anaplastic astrocytomas (AAs). Immunostaining was used to determine whether genes showing the most positive correlation with necrosis were increasingly expressed in tumor tissues, as grade of necrosis increased. Results: The hybridization results indicated that 26 genes showed significant correlation with the amount of necrosis. All 26 genes had functions associated with either Ras, Akt, tumor necrosis factor α, nuclear factor κB, apoptosis, procoagulation, or hypoxia. Nine genes were positively correlated with necrosis grade, and 17 genes were negatively correlated with necrosis grade. There were significant differences in the median expression levels of 3 of the 26 genes between grade III necrosis GBM and anaplastic astrocytoma (AA) samples; all but 1 of the genes had elevated expression when comparing necrosis grade III with AA samples. Two factors, the ephrin type A receptor 1 and the prostaglandin E2 receptor EP4 subtype, not previously considered in this context, were highlighted because of their particularly high (positive) correlation coefficients; immunostaining showed the products of these two genes to be localized in perinecrotic and necrotic regions and to be overexpressed in grade III GBMs, but not AAs. These two molecules also showed significant correlation with survival of GBM patients (P = 0.0034) in a combined model. Conclusions: The application of cDNA expression microarray analysis has identified specific genes and patterns of gene expression that may help elucidate the molecular basis of necrogenesis in GBM. Additional studies will be required to further investigate and confirm these findings.

Từ khóa


Tài liệu tham khảo

Farber E. Programmed cell death: necrosis versus apoptosis. Mod. Pathol., 7: 605-609,  1994.

Kerr J. F. Shrinkage necrosis: a distinct mode of cellular death. J. Pathol., 105: 13-20,  1971.

Hammoud M. A., Sawaya R., Shi W., Thall P. F., Leeds N. E. Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J. Neuro-Oncol., 27: 65-73,  1996.

Roessler K., Suchanek G., Breitschopf H., Kitz K., Matula C., Lassmann H., Koos W. T. Detection of tumor necrosis factor α protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes. J. Neurosurg., 83: 291-297,  1995.

Fuller G. N., Rhee C. H., Hess K. R., Caskey L. S., Wang R., Bruner J. M., Yung W. K., Zhang W. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res., 59: 4228-4232,  1999.

Raza S. M., Lang F. F., Aggarwal B. B., Fuller G. N., Wildrick D. M., Sawaya R. Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis. Neurosurgery (Baltimore), 51: 2-13,  2002.

Adams R. H., Klein R. Eph receptors and ephrin ligands. essential mediators of vascular development. Trends Cardiovasc. Med., 10: 183-188,  2000.

Ahmed A., Dunk C., Ahmad S., Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen: a review. Placenta, 21: ((Suppl. A))S16-S24,  2000.

Airoldi I., Gri G., Marshall J. D., Corcione A., Facchetti P., Guglielmino R., Trinchieri G., Pistoia V. Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells. J. Immunol., 165: 6880-6888,  2000.

Akiyoshi S., Inoue H., Hanai J., Kusanagi K., Nemoto N., Miyazono K., Kawabata M. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with smads. J. Biol. Chem., 274: 35269-35277,  1999.

Bowlin T. L., Borcherding D. R., Edwards C. K., III, McWhinney C. D. Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor α production in vitro and in vivo. Cell. Mol. Biol. (Noisy-Le-Grand), 43: 345-349,  1997.

Choi K. C., Kang S. K., Tai C. J., Auersperg N., Leung P. C. Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells. Endocrinology, 142: 2351-2360,  2001.

Dadi H., Ke S., Roifman C. M. Activation of phosphatidylinositol-3 kinase by ligation of the interleukin-7 receptor is dependent on protein tyrosine kinase activity. Blood, 84: 1579-1586,  1994.

Daugas E., Nochy D., Ravagnan L., Loeffler M., Susin S. A., Zamzami N., Kroemer G. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett., 476: 118-123,  2000.

Denecker G., Vercammen D., Declercq W., Vandenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cell. Mol. Life Sci., 58: 356-370,  2001.

Easty D. J., Hill S. P., Hsu M. Y., Fallowfield M. E., Florenes V. A., Herlyn M., Bennett D. C. Up-regulation of ephrin-A1 during melanoma progression. Int. J. Cancer, 84: 494-501,  1999.

Eberl L. P., Egidy G., Pinet F., Juillerat-Jeanneret L. Endothelin receptor blockade potentiates FasL-induced apoptosis in colon carcinoma cells via the protein kinase C-pathway. J. Cardiovasc. Pharmacol., 36: S354-S356,  2000.

Falany J. L., Falany C. N. Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells. Oncol. Res., 9: 589-596,  1997.

Flory E., Hoffmeyer A., Smola U., Rapp U. R., Bruder J. T. Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter. J. Virol., 70: 2260-2268,  1996.

Fowler D. J., Nicolaides K. H., Miell J. P. Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. Hum. Reprod. Update, 6: 495-504,  2000.

Gao Z., Li B. S., Day Y. J., Linden J. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol. Pharmacol., 59: 76-82,  2001.

Gold M. R., Ingham R. J., McLeod S. J., Christian S. L., Scheid M. P., Duronio V., Santos L., Matsuuchi L. Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase. Immunol. Rev., 176: 47-68,  2000.

Greene R. A. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer’s disease. Int. J. Fertil. Women’s Med., 45: 253-257,  2000.

Gruss H. J. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Int. J. Clin. Lab. Res., 26: 143-159,  1996.

Hofmeister R., Khaled A. R., Benbernou N., Rajnavolgyi E., Muegge K., Durum S. K. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev., 10: 41-60,  1999.

Holland E. C., Celestino J., Dai C., Schaefer L., Sawaya R. E., Fuller G. N. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet., 25: 55-57,  2000.

Jacobson K. A. Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharmacol. Sci., 19: 184-191,  1998.

Kaltschmidt B., Kaltschmidt C., Hehner S. P., Droge W., Schmitz M. L. Repression of NF-κB impairs HeLa cell proliferation by functional interference with cell cycle checkpoint regulators. Oncogene, 18: 3213-3225,  1999.

Kast R. E. Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMP. Int. J. Immunopharmacol., 22: 1001-1006,  2000.

Kitaura J., Asai K., Maeda-Yamamoto M., Kawakami Y., Kikkawa U., Kawakami T. Akt-dependent cytokine production in mast cells. J. Exp. Med., 192: 729-740,  2000.

Klaassen C. D., Liu L., Dunn R. T., II. Regulation of sulfotransferase mRNA expression in male and female rats of various ages. Chem. Biol. Interact., 109: 299-313,  1998.

Kondo N., Matsui E., Kaneko H., Fukao T., Teramoto T., Inoue R., Watanabe M., Kasahara K., Morimoto N. Reduced interferon-γ production and mutations of the interleukin-12 receptor β2 chain gene in atopic subjects. Int. Arch. Allergy Immunol., 124: 117-120,  2001.

Kotov A., Falany J. L., Wang J., Falany C. N. Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells. J. Steroid Biochem. Mol. Biol., 68: 137-144,  1999.

Lazaar A. L., Amrani Y., Hsu J., Panettieri R. A., Jr., Fanslow W. C., Albelda S. M., Pure E. CD40-mediated signal transduction in human airway smooth muscle. J. Immunol., 161: 3120-3127,  1998.

Lin C. G., Lin Y. C., Liu H. W., Kao L. S. Characterization of Rab3A, Rab3B and Rab3C: different biochemical properties and intracellular localization in bovine chromaffin cells. J. Biochem. (Tokyo), 324: 85-90,  1997.

Lin T. N., Wang C. K., Cheung W. M., Hsu C. Y. Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion. J. Cereb. Blood Flow Metab., 20: 387-395,  2000.

Los M., Neubuser D., Coy J. F., Mozoluk M., Poustka A., Schulze-Osthoff K. Functional characterization of DNase X, a novel endonuclease expressed in muscle cells. Biochemistry, 39: 7365-7373,  2000.

Ludviksson B. R., Seegers D., Resnick A. S., Strober W. The effect of TGF-β1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells. Eur. J. Immunol., 30: 2101-2111,  2000.

McKiernan C. J., Stabila P. F., Macara I. G. Role of the Rab3A-binding domain in targeting of rabphilin-3A to vesicle membranes of PC12 cells. Mol. Cell. Biol., 16: 4985-4995,  1996.

McWhinney C. D., Dudley M. W., Bowlin T. L., Peet N. P., Schook L., Bradshaw M., De M., Borcherding D. R., Edwards C. K., III. Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor α. Eur. Pharmacol., 310: 209-216,  1996.

Melter M., Reinders M. E., Sho M., Pal S., Geehan C., Denton M. D., Mukhopadhyay D., Briscoe D. M. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood, 96: 3801-3808,  2000.

Menouny M., Binoux M., Babajko S. IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity. Int. J. Cancer, 77: 874-879,  1998.

Morawietz H., Talanow R., Szibor M., Rueckschloss U., Schubert A., Bartling B., Darmer D., Holtz J. Regulation of the endothelin system by shear stress in human endothelial cells. J. Physiol. (Cambridge), 525: 761-770,  2000.

Morga E., Faber C., Heuschling P. Stimulation of endothelin B receptor modulates the inflammatory activation of rat astrocytes. J. Neurochem., 74: 603-612,  2000.

Mosnier L. O., Meijers J. C., Bouma B. N. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin. Thromb. Haemostasis, 85: 5-11,  2001.

Naldini A., Carraro F. Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation. J. Cell. Physiol., 181: 448-454,  1999.

Ogawa K., Pasqualini R., Lindberg R. A., Kain R., Freeman A. L., Pasquale E. B. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene, 19: 6043-6052,  2000.

Ohana G., Bar-Yehuda S., Barer F., Fishman P. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. J. Cell. Physiol., 186: 19-23,  2001.

Paul B. Z., Ashby B., Sheth S. B. Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells. Br. J. Haematol., 102: 1204-1211,  1998.

Perkins N. D., Felzien L. K., Betts J. C., Leung K., Beach D. H., Nabel G. J. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science (Wash. DC), 275: 523-527,  1997.

Proietti De Santis L., Garcia C. L., Balajee A. S., Brea Calvo G. T., Bassi L., Palitti F. Transcription coupled repair deficiency results in increased chromosomal aberrations and apoptotic death in the UV61 cell line, the Chinese hamster homologue of Cockayne’s syndrome B. Mutat. Res., 485: 121-132,  2001.

Rivera I., Harhaj E. W., Sun S. C. Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation. J. Biol. Chem., 273: 22382-22388,  1998.

Rodriguez A. M., Rodin D., Nomura H., Morton C. C., Weremowicz S., Schneider M. C. Identification, localization, and expression of two novel human genes similar to deoxyribonuclease I. Genomics, 42: 507-513,  1997.

Roifman C. M., Zhang J., Chitayat D., Sharfe N. A partial deficiency of interleukin-7R α is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood, 96: 2803-2807,  2000.

Rothstein T. L. Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res., 10: 245-266,  2000.

Salatino M., Labriola L., Schillaci R., Charreau E. H., Elizalde P. V. Mechanisms of cell cycle arrest in response to TGF-β in progestin-dependent and -independent growth of mammary tumors. Exp. Cell Res., 265: 152-166,  2001.

Salvatore C. A., Tilley S. L., Latour A. M., Fletcher D. S., Koller B. H., Jacobson M. A. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J. Biol. Chem., 275: 4429-4434,  2000.

Schonbeck U., Mach F., Sukhova G. K., Herman M., Graber P., Kehry M. R., Libby P. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am. J. Pathol., 156: 7-14,  2000.

Sharma V. K., Bologa R. M., Li B., Xu G. P., Lagman M., Hiscock W., Mouradian J., Wang J., Serur D., Rao V. K., Suthanthiran M. Molecular executors of cell death: differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation (Baltimore), 62: 1860-1866,  1996.

Shinomiya S., Naraba H., Ueno A., Utsunomiya I., Maruyama T., Ohuchida S., Ushikubi F., Yuki K., Narumiya S., Sugimoto Y., Ichikawa A., Oh-ishi S. Regulation of TNFα and interleukin-10 production by prostaglandins I2 and E2: studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochem. Pharmacol., 61: 1153-1160,  2001.

Shirakawa K., Tsuda H., Heike Y., Kato K., Asada R., Inomata M., Sasaki H., Kasumi F., Yoshimoto M., Iwanaga T., Konishi F., Terada M., Wakasugi H. Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res., 61: 445-451,  2001.

Shneyvays V., Jacobson K. A., Li A. H., Nawrath H., Zinman T., Isaac A., Shainberg A. Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol. Exp. Cell Res., 257: 111-126,  2000.

Simpson R. B., Chase C. C., Jr., Spicer L. J., Carroll J. A., Hammond A. C., Welsh T. H., Jr. Effect of exogenous estradiol on plasma concentrations of somatotropin, insulin-like growth factor-I, insulin-like growth factor binding protein activity, and metabolites in ovariectomized Angus and Brahman cows. Domest. Anim. Endocrinol., 14: 367-380,  1997.

Sokolovsky M., Ambar I., Galron R. A novel subtype of endothelin receptors. J. Biol. Chem., 267: 20551-20554,  1992.

Tilley S. L., Audoly L. P., Hicks E. H., Kim H. S., Flannery P. J., Coffman T. M., Koller B. H. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J. Clin. Investig., 103: 1539-1545,  1999.

Venkitaraman A. R., Cowling R. J. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the α chain of the interleukin-7 receptor. Eur. J. Immunol., 24: 2168-2174,  1994.

Williams J. G., Garcia I., Maier R. V. Prostaglandin E2 mediates lipopolysaccharide-induced macrophage procoagulant activity by a cyclic adenosine monophosphate-dependent pathway. Surgery (St. Louis), 114: 314-323,  1993.

Xu H., Zhang G. X., Wysocka M., Wu C. Y., Trinchieri G., Rostami A. The suppressive effect of TGF-β on IL-12-mediated immune modulation specific to a peptide Ac1–11 of myelin basic protein (MBP): a mechanism involved in inhibition of both IL-12 receptor β1 and β2. J. Neuroimmunol., 108: 53-63,  2000.

Yabkowitz R., Meyer S., Black T., Elliott G., Merewether L. A., Yamane H. K. Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood, 93: 1969-1979,  1999.

Yue Y., Su J., Cerretti D. P., Fox G. M., Jing S., Zhou R. Selective inhibition of spinal cord neurite outgrowth and cell survival by the Eph family ligand ephrin-A5. J. Neurosci., 19: 10026-10035,  1999.

Zhou R. The Eph family receptors and ligands. Pharmacol. Ther., 77: 151-181,  1998.

Ziche M., Maglione D., Ribatti D., Morbidelli L., Lago C. T., Battisti M., Paoletti I., Barra A., Tucci M., Parise G., Vincenti V., Granger H. J., Viglietto G., Persico M. G. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab. Investig., 76: 517-531,  1997.

Chang F., Steelman L. S., McCubrey J. A. Raf-induced cell cycle progression in human TF-1 hematopoietic cells. Cell Cycle, 1: 220-226,  2002.

Green C. J., Lichtlen P., Huynh N. T., Yanovsky M., Laderoute K. R., Schaffner W., Murphy B. J. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res., 61: 2696-2703,  2001.

Nomura M., Yamagishi S., Harada S., Yamashima T., Yamashita J., Yamamoto H. Placenta growth factor (PlGF) mRNA expression in brain tumors. J. Neuro-Oncol., 40: 123-130,  1998.

Shinagawa T., Dong H. D., Xu M., Maekawa T., Ishii S. The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice. EMBO J., 19: 2280-2291,  2000.

Thông tin
Thông tin xuất bản

Clinical Cancer Research

Tập 10 Số 1

212-221

Thông tin tác giả